DEFINITIONS
Biochemical pregnancy loss or miscarriage is the pregnancy loss, which occurs after positive urinary or serum human chorionic gonadotropin (hCG), but before ultrasound or histological detection of pregnancy (<6 weeks) [1] .
Clinical pregnancy loss or miscarriage is the pregnancy loss, which occurs after ultrasound detection of intrauterine gestational sac, and confirmed by histological evidence of products of conception after the miscarriage [1] . Clinical miscarriages divided to; early clinical pregnancy losses (<12 weeks), and late clinical pregnancy losses (between 12-21 weeks). The ESHRE (European Society of Human Reproduction, and Embryology) defined RM as ≥3 consecutive pregnancy losses before 22 weeks [2] .
EPIDEMIOLOGY OF MISCARRIAGE
The use of sensitive, and accurate urinary hCG assays in the diagnosis of pregnancy demonstrated that only one-third of conceptions progress to a live birth. Thirty percent of human conceptions are lost before implantation, and another 30% after implantation but before the missed menses (3 rd or 4 th week), and both termed as preclinical losses [3] . Figure 1 The incidence of early clinical miscarriage is about 10-15%. The incidence of late miscarriage is about 4% [4] . Compared to sporadic miscarriage the incidence of RM is 0.8-1.4% if only clinical pregnancy included, and 2-3% if biochemical pregnancy included [4] . Maternal age, and number of previous miscarriages are two independent risk factors for a further miscarriage [5] . The incidence of early miscarriage significantly increased with advanced maternal age, from 10-15% in women aged 20 to 24 years to 51% in women aged 40 to 44 years [5] . The risk of miscarriage is much higher in women with previous losses. The risk of miscarriage after two consecutive losses is between 17-25%, and the risk of miscarriage after three consecutive losses is between 25-46% [2, 5] .
Figure1: The outcome of conception; 60% preclinical miscarriage, 10% clinical miscarriage, and 30% live birth
Advanced paternal age has also been identified as a risk factor for miscarriage. The risk of miscarriage is highest among couples where the woman is ≥35 years of age, and the man ≥40 years of age [6] .
Current evidence is insufficient to confirm the association between maternal cigarette smoking, caffeine consumption, and increased risk of spontaneous miscarriage [7] [8] . Moderate alcohol consumption of ≥ 5 units per week may increase the risk of sporadic miscarriage [9] . Recent retrospective studies have reported that obesity increases the risk of both sporadic, and RM [10] [11] [12] .
PHYSIOLOGY OF EARLY MISCARRIAGE
Sporadic miscarriage occurs before embryo development could represent a physiological phenomenon, which prevents congenitally malformed or chromosomally abnormal embryos to progress to viability. Chromosomal abnormalities incompatible with life observed in 85% of early clinical miscarriages, and chromosomal aberrations are responsible for 29-60% of RM [13] . However, some aneuploidies can survive to term pregnancy as trisomy 21. The fetal chromosomal abnormalities of maternal origin are related to the advanced maternal age, and occurs during the first meiotic division [5] . Recently; the fetal DNA containing cells isolated from the maternal plasma from the 7 th weeks for prenatal diagnosis of fetal genetic and / or chromosomal abnormalities [14] . 
Table1. Causes of Miscarriage

Chromosomal Abnormalities
Approximately 50-60% of early spontaneous miscarriages associated with aneuploidy, especially autosomal trisomy [15] . In couples with RM, increases with advancing maternal age [5] . However, parental karyotyping is not predictive for the subsequent pregnancy outcome, and routine karyotyping in RM is not recommended [16] .
A large-controlled study showed that carrier couples with two miscarriages had the same chance of having a healthy child as non-carrier with the same number of miscarriages (83% versus 84%; respectively) [16] . Cytogenetic analysis should be performed on products of conception of the third, and subsequent consecutive miscarriage(s), and parental peripheral blood karyotyping of both partners should be performed in couples with RM where testing of products of conception reports an unbalanced structural chromosomal abnormality [16] .
[ Evidence 3] IVF/PGD suggested as faster method of conception than natural conception for translocation carriers couples or couples with chromosomal abnormalities, and RM [17] .
[Evidence 4]
Immunological causes
Failure of the maternal immune recognition, and fetal antigen expression mechanisms involved in the fetal rejection, and subsequent RM. Although, there was no proof that the auto antibodies as; anti-phospholipid, anti-thyroid, and anti-nuclear have harmful or negative effect on pregnancy, those auto antibodies used as markers of immunological dysfunction or disruption in RM.
Studies reported increased levels of T helper cell cytokines or natural killer (NK) cells in the blood of women with euploid sporadic miscarriage, and in RM, but it is not clear whether the peripheral blood levels of those biomarkers reflects their levels at the fetomaternal interface or not [18] . Although, the uterine NK cells play an important role in implantation, a systematic review concluded that the NK cells (both peripheral blood and uterine) are not predictive for the pregnancy outcome in RM [19] . The evidence of involvement of the immune system in miscarriage comes from genetic studies.
These studies showed that some genetic biomarkers of possible importance for immunologic dysfunction in pregnancy were found in women with RM. Those biomarkers are; maternal HLA class against male-specific antigens of male embryos, specific maternal NK cell receptor that associated with maternal NK cell recognition of the trophoblast [20] . Prednisone, intravenous immunoglobulin (IVIG), and tumor necrosis factor α (TNFα) antagonists or granulocyte colony-stimulating factor (G-CSF) suggested as treatment for cases presented with RM due to immunologic dysfunction. The majority of those treatments have only tested in small RCTs, and the efficacy of them are controversial [21] .
[Evidence 1++]
A meta-analysis showed that the use of IVIG improved the live birth rates in women with secondary RM compared to placebo, but the effect was not significant [22] . The use of unfractionated or LMWH in mice prevent complement activation, and pregnancy complications caused by IgG from women with APS [23] .
Thrombophilias a) Acquired Thrombophilia
Antiphospholipid syndrome (APS) is the only proven thrombophilia associated with adverse pregnancy outcomes. Five to fifteen percent of RM women have elevated aPL-Abs compared to 2-5% of the controls [24] . APS refers to the association between antiphospholipid antibodies (lupus anticoagulant, anticardiolipin antibodies and anti-B2 glycoprotein-I antibodies), and adverse pregnancy outcome and/or vascular thrombosis. Adverse pregnancy outcomes include: 1) ≥ one unexplained fetal deaths of morphologically normal fetus ≥10 th weeks; 2) severe pre-eclampsia or placental insufficiency <34 weeks; 3) ≥3 unexplained consecutive miscarriages <10th weeks [24] [25] [26] . The APS diagnosed by one of the adverse pregnancy outcome, and one laboratory criteria. Laboratory criteria include; positive Anti-cardiolipin (ACL) antibodies or high level of Anti-β2 glycoprotein-I antibodies on ≥2 occasions (12 weeks apart) [25, 26] .
b) Inherited Thrombophilia
Inherited thrombophilias includes; factor V Leiden, prothrombin gene mutations, protein C resistance, and protein S deficiency [24] . Although, the previous studies found significant association between inherited thrombophilias, and still births after the 20 th weeks, rather than early pregnancy loss [24] .
A meta-analysis suggested that the association between inherited thrombophilias, and fetal loss varies according to the type of fetal loss, and type of thrombophilia. In this meta-analysis, factor V Leiden was associated with recurrent first-trimester fetal loss, recurrent fetal loss after 22 weeks, and non-recurrent fetal loss after 19 weeks. Activated protein C resistance was associated with recurrent first-trimester fetal loss. Prothrombin gene mutation was associated with recurrent first-trimester fetal loss, recurrent fetal loss before 25 weeks, and late nonrecurrent fetal loss. Protein S deficiency was associated with recurrent fetal loss and nonrecurrent fetal loss after 22 weeks [27] .
[Evidence 2++]
Similarly, another meta-analysis reported that carriers of factor V Leiden or prothrombin gene mutation have double the risk of RM compared with controls [28] .
[Evidence 2++] c) MTHFR Gene Mutation
Methylenetetrahydrofolate reductase (MTHFR) is an enzyme that convert 5,10-MTHF (methyltetrahydrofolate) into 5-MTHF (circulating form of folate). MTHFR mutation associated with hyperhomocysteinemia, which considered a risk factor for neural tube defects, and RM [29] .
Endocrine Causes a) Polycystic Ovary Syndrome (PCOS), and Insulin Resistance (IR)
PCO is common ultrasound finding seen in 40% of women with RM, studies showed that PCO is not predictive for the pregnancy outcome after spontaneous conception [30] . However, recent meta-analysis concluded that IR, and hyperinsulinaemia in PCOS women associated with increased susceptibility to RM [31] .
[Evidence 1++] b) Luteal Phase Defect (LPD)
LPD associated with pregnancy loss, but the diagnosis of LPD using the histological, and the biochemical markers for endometrial dating are unreliable.
c) Diabetes Mellitus (DM)
Diabetic women who have high HbA1c levels in the first trimester are at risk of miscarriage, and fetal malformation [32] . HbA1c (glycosylated hemoglobin) gains an important role in diagnosis of DM/GDM because oral glucose tolerance test (OGTT) is not a perfect test. In addition; fasting plasma glucose would miss women with glucose intolerance [33] .
d) Thyroid Disorders
Subclinical hypothyroidism with pregnancy associated with increased RM risk. A metaanalysis found that the risk of sporadic and/or RM increased in women with positive thyroperoxidase antibodies (TPO-Ab) [34] . In addition; the risk of miscarriage doubled in women with TSH >2.5 mIU/L in the first trimester [34] .
[Evidence 1+]
Only a single prospective study has shown that the presence of thyroid antibodies in euthyroid women with a history of RM does not affect future pregnancy outcome [35] . [Evidence 3]
Sperm DNA Fragmentation
A meta-analysis found that the risk of miscarriage increased in couples where the male partner had elevated levels of sperm DNA damage compared to controls with no or low levels of sperm DNA damage [36] . In addition; the paternal role in RM suggested in another studies, which showed that 85% of the RM couples had high levels of double-stranded sperm DNA damage compared to 33% of the controls [37] .
Failure of Embryo Selection
The decidual endometrial stromal cells (ESCs) act as biosensor for embryonic signals, and able to select the embryos for implantation based on their qualities. The first study demonstrated the biosensor function of ESCs showed reduced production of the regulatory cytokines of implantation in response to poor quality or nonviable embryos [38] . These findings provided the first explanation to the hypothesis suggested by Quenby et al, that women with RM may allow embryos of poor quality to implant inappropriately [39] . In women with RM the endometrial selectivity to embryos of good quality is disrupted, and they allow low quality embryos to implant rather than lost as preclinical biochemical pregnancy [40] . Moreover, ESCs of women with RM showed prolonged receptivity (super receptivity), with low selectivity for low quality embryos [40] . A recent study showed that the migration of ESCs from RM women was similar in the presence of low-quality or high quality embryos [41] .
Uterine Malformations
Uterine malformations associated with RM are; didelphic, bicornuate, arcuate, and septate uteri. A large systematic review showed by that, the prevalence of uterine malformations was 15.4% among RM women compared to 5.5% among controls [42] .
Kowalik et al, showed that the first trimester miscarriage significantly increased in women with septate uteri compared to controls, and they suggested a positive effect of septal resection on the pregnancy outcome [43] . The combination of hysteroscopy, and laparoscopy is the gold standard method for the diagnosis of the uterine malformations.
The three dimensional ultrasound is more accurate than 2D ultrasound, and equal to MRI for the diagnosis of the uterine malformations [44] . Saline sonohysterography (SIS) is a non-invasive, cost-effective method with 95% accuracy in identifying the uterine malformations, and Reda et al, suggest that there is a good role of SIS in the workup for recurrent implantation failure (RIF) saving more invasive procedure for selected cases [45] . The two dimensional ultrasound can used as an initial screening tool for the diagnosis of uterine malformations, while, combined hysteroscopy, and laparoscopy, SIS, MRI, and 3D ultrasound can used as confirmatory tools [44] .
hCG Gene Polymorphisms
hCG is glycoprotein consist of α and β subunits, secreted by syncytiotrophoblast to maintain the progesterone secretion from the corpus luteum in early pregnancy. Early miscarriage associated with low hCG levels in maternal blood. The low hCG levels in maternal blood may be due to; (1) impaired trophoblast growth caused by aneuploidy, thrombophilia or immune dysfunctions with low hCG production (external hCG treatment will not be beneficial), or (2) primary trophoblastic failure with subsequent inadequate hCG secretion from the trophoblast (treatable with hCG or progesterone therapy). The β subunit of hCG is coded by 4 chorionic gonadotropin β (CGB) genes, and the CGB5 and the CGB8 are the most active [46] . A polymorphisms in the promoter region of the CGB5 gene that enhance hCG-β transcription suggested, because lower levels of both hCG, and hCG-β mRNA found in the tissue from RM women [46] .
Life Style Factors
Alcohol increase the risk of miscarriage significantly, and the national Danish birth study, suggested that the risk increased in a dose related manner [47] . Another Danish study, demonstrated increase risk of miscarriage in women drinking >7 cups of coffee per day [48] , and a large prospective study could not demonstrate an association between smoking, and miscarriage [49] . A meta-analysis concluded that women with body mass index (BMI) ≥25 kg/m 2 are at high risk of miscarriage compared to women with BMI <25 kg/m 2 [11] . A logistic analysis showed that the BMI ≥30 kg/m 2 was the most important risk factor after the advanced maternal age to predict another miscarriage [12] .
A systematic review investigating the relation between miscarriage, and obesity after spontaneous conception, showed significant association between obesity, and both sporadic and RM [50] .
Infections
The role of infection in RM is unclear, and for any infective agent to cause RM, it must be capable of persisting in the genital tract, and avoiding of detection.
[Evidence 3]
Bacterial vaginosis is a risk factor for secondtrimester miscarriage, and preterm labor (PTL), and a RCT reported that treatment of bacterial vaginosis early in the second trimester significantly reduces the incidence of secondtrimester miscarriage, and PTL [51] .
MANAGEMENT
Psychological support, and counseling are crucial during the evaluation, and treatment of RM. The value of psychological support in improving pregnancy outcome has not been tested in RCTs. However, data from several non-randomized studies suggested that attendance at a dedicated early pregnancy clinic has a beneficial effect, through unknown mechanism [52, 53] . [Evidence 2+] Genetic counselling offers the couple a prognosis for the risk of future pregnancies with an unbalanced chromosome complement, and the opportunity for familial chromosome studies. Healthy life style, free from alcohol, tobacco, and undue stress may significantly improve the chances for successful pregnancy [54] . A Cochrane review concluded that the vitamin supplements before or during pregnancy did not prevent sporadic or RM [55] .
Genetic Anomalies: A Dutch study reported that couples with balanced translocations have a low risk (0.8%) of pregnancies with an unbalanced karyotype surviving into the second trimester, and that their chance of having a healthy child is 83% [16] .
[Evidence 3]
A recent retrospective UK audit reported that balanced translocations were found in 1.9% of parents with RM, but only four unbalanced translocations were found after referral for prenatal diagnosis. The audit concluded that routine karyotyping of couples with RM cannot be justified [56] .
IVF/PGD suggested as faster method of conception than natural conception for translocation carriers couples or couples with chromosomal abnormalities, and RM [55] [56] [57] [58] [59] . However, studies showed that the IVF/PGD treatment in women with unexplained RM does not improve live birth rates, and the live birth rate of women with unexplained RM who conceive naturally is significantly higher than currently achieved after PGD/IVF [60] [61] .
[Evidence 2+]
Anatomical Defects: The majority of women (65-85%) with uterine malformations as septate uterus have successful pregnancy after metroplasty, and 59.5% of women with such anomalies have successful subsequent pregnancy without surgery. Although, there is no strong evidence to recommend metroplasty in women with septate uterus [43] .
Hysteroscopic metroplasty should be done only for women with septate uteri, after failed previous IVF-ET trials [43] . In addition; the hysteroscopic metroplasty should done under laparoscopic guidance (combined hysterolaparoscopy) to avoid uterine perforation, and bowel injury during the procedure.
Although, the CERVO trial failed to find any benefit for the cervical cerclage in women with incompetent cervix [62] . Another study; concluded that the Shirodkar technique was more effective than McDonald technique in women with single pregnancy undergoing ultrasound-indicated cervical cerclage [63] . Cervical cerclage, and vaginal progesterone are equally effective in prevention of PTL in women with single pregnancy, and short cervix (less than 25 mm) detected by mid-trimester trans-vaginal scan [64] .
[Evidence 1+]
Infection: Treatment of asymptomatic bacterial vaginosis with clindamycin early in the second trimester significantly reduces the risks of late miscarriage, and PTL [51] .
Endocrine Disorders: Maternal endocrine disorders (diabetes, thyroid dysfunction) should treated before pregnancy. Hyperprolactinemia usually result in RM through impaired oocyte maturation, and LPD. Normalization of prolactin levels with dopamine agonist significantly improves the pregnancy outcomes [65] . Thyroid disorders should treated to achieve euthyroid status before pregnancy. A consensus is emerging that TSH values >2.5 mIU/L are outside the normal range, and TSH should maintained at <2.5 mU/L during pregnancy. Evidence suggests association between TPOAb, and RM, and recommends Levothyroxine 50 μg daily for women with TPO-Ab even in presence of normal TSH [66] .
Progesterone: Progesterone is an immunemodulator, produces progesterone-induced blocking factors (PIBF) from the lymphocytes, and the PIBF inhibits cell-mediated cytotoxicity, and NK cells activity [67] . Progesterone therapy is ineffective for women with sporadic miscarriages, and may be beneficial for women with ≥3 consecutive miscarriages immediately preceding their current pregnancy [68] .
Metformin: No adequate published data or trials supporting the use metformin to decrease the risk spontaneous of miscarriages. Clinicians should advise women with IR to improve their insulin sensitivity through lifestyle modification or medical treatment before pregnancy to reduce the risk of spontaneous miscarriages. Nonrandomized studies showed that the use of metformin reduces IR in PCOS women, and may reduce the risk of miscarriages [69] .
[Evidence 1++]
A meta-analysis of RCTs in women with PCOS, and infertility showed that metformin has no effect on the sporadic miscarriage risk when administered before pregnancy. However, there are no RCTs to assess the role of metformin RM women [70] .
APS: Meta-analysis of RCTs reported that the only treatment that leads to a significant increase in the live birth rate among women with APS is aspirin plus unfractionated heparin or LMW heparin [71] . This treatment combination significantly reduces the miscarriage rate by 54%, and steroids associated with significant maternal, and fetal morbidity [72, 73] .
[Evidence 1+]
Inherited Thrombophilia: There is insufficient evidence about the effect of heparin in prevention of first-trimester RM in women with inherited thrombophilia. One prospective RCT demonstrated that the live birth rate of women treated with enoxaparin after history of single miscarriage >10 weeks due to inherited thrombophilia was 86% compared with 29% in women treated with low-dose aspirin alone [74] .
MTHFR Mutation: High-dose folic acid (5 mg), and vitamin B12 (0.5 mg) reduce the levels of homocysteine, and high-dose folic acid recommended for diabetic women with high BMI.
Immunotherapy: IVIG may work in women with RM through CD94 expression, and suppression of NK cell cytotoxicity [75] . Evidence does not support the use of intralipid in RM [76] . A Cochrane systematic review has shown that the use of various forms of immunotherapy in women with unexplained RM provides no significant beneficial effect over placebo in preventing further miscarriage [21] .
[Evidence 1++]
Meta-analysis showed that the use IVIG increased the live birth rates in secondary RM, and the evidence for its use in primary RM was insufficient [77] [78] .
Unexplained RM: Psychological support: Data from several non -randomized studies suggested that attendance at a dedicated early pregnancy clinic has a beneficial effect, through unknown mechanism [52, 53] .
[Evidence 2+]
Aspirin (75 mg daily): Aspirin improves the uterine perfusion, and useful in many undiagnosed implantation failure. Few RCT suggested clear benefit of aspirin in RM, while, the recent trials failed to support its role in unexplained RM [79] .
[Evidence 1+]
Progesterone: Meta-analysis showed significant reduction in miscarriage rates with the use of progesterone [80] , and a large multicenter study (PROMISE, http://www.medscinet.net/promise) is currently going to assess the benefit of progesterone in unexplained RM. [Evidence 1+] hCG: Recent Cochrane review failed to find good evidence to support the use of hCG in prevention of miscarriage [81] . A multicenter placebo-controlled study in early pregnancy failed to show any benefit for hCG in pregnancy outcome [82] .
Steroids: Meta-analysis of RCTs reported that the only treatment that leads to significant increase in the live birth rate among women with APS is aspirin plus heparin, and steroids associated with significant maternal, and fetal morbidity [72, 73] .
Steroid therapy may be useful in some women with RM because of its effect on the endometrial growth factors [83] .
Immunoglobulins: IVIG administration for treatment of RM is not justified outside the context of research.
SUMMARY
APS is the only proven thrombophilia associated with adverse pregnancy outcomes, and aspirin plus heparin is the only treatment associated with reduction of miscarriage rate. The association between inherited thrombophilias, and fetal loss varies according to the type of fetal loss, and type of thrombophilia.
IR in PCOS associated with increased susceptibility to RM, and non-randomized trials showed that the use of metformin reduces IR in PCOS, and may reduce the risk of miscarriages.
The risk of miscarriage doubled in women with TSH >2.5 mIU/L in the first trimester, evidence suggests association between TPO-Ab, and RM. Although, the majority of women have successful pregnancy after metroplasty, there is no strong evidence to recommend metroplasty in women with septate uterus. Cervical cerclage, and vaginal progesterone are equally effective in prevention of PTL in women with single pregnancy, and short cervix (< 25 mm) detected by TVS. Progesterone therapy may be beneficial for women with ≥3 consecutive miscarriages immediately preceding their current pregnancy. The live birth rate of women with unexplained RM who conceive naturally is significantly higher than currently achieved after PGD/IVF. Evidence failed to show any benefit for hCG and/or aspirin in unexplained RM. Steroids, IVIG, TNFα antagonists and/or G-CSF efficacy in RM due to immunologic dysfunction are controversial. 
